NovaBay Pharmaceuticals
14 hedge funds and large institutions have $1.1M invested in NovaBay Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$647K | |
| 2 | +$145K | |
| 3 | +$63K | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$35K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$34K |
Top Sellers
| 1 | -$128K | |
| 2 | -$15K | |
| 3 | -$11K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$6K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4.25K |